11-46725515-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000506.5(F2):​c.560-344C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.141 in 152,140 control chromosomes in the GnomAD database, including 2,456 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 2456 hom., cov: 32)

Consequence

F2
NM_000506.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.69

Publications

8 publications found
Variant links:
Genes affected
F2 (HGNC:3535): (coagulation factor II, thrombin) This gene encodes the prothrombin protein (also known as coagulation factor II). This protein is proteolytically cleaved in multiple steps to form the activated serine protease thrombin. The activated thrombin enzyme plays an important role in thrombosis and hemostasis by converting fibrinogen to fibrin during blood clot formation, by stimulating platelet aggregation, and by activating additional coagulation factors. Thrombin also plays a role in cell proliferation, tissue repair, and angiogenesis as well as maintaining vascular integrity during development and postnatal life. Peptides derived from the C-terminus of this protein have antimicrobial activity against E. coli and P. aeruginosa. Mutations in this gene lead to various forms of thrombosis and dysprothrombinemia. Rapid increases in cytokine levels following coronavirus infections can dysregulate the coagulation cascade and produce thrombosis, compromised blood supply, and organ failure. [provided by RefSeq, May 2020]
F2 Gene-Disease associations (from GenCC):
  • thrombophilia due to thrombin defect
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • congenital prothrombin deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.574 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000506.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F2
NM_000506.5
MANE Select
c.560-344C>G
intron
N/ANP_000497.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F2
ENST00000311907.10
TSL:1 MANE Select
c.560-344C>G
intron
N/AENSP00000308541.5
F2
ENST00000862106.1
c.655+169C>G
intron
N/AENSP00000532165.1
F2
ENST00000862118.1
c.560-344C>G
intron
N/AENSP00000532177.1

Frequencies

GnomAD3 genomes
AF:
0.141
AC:
21368
AN:
152022
Hom.:
2444
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0309
Gnomad AMI
AF:
0.0811
Gnomad AMR
AF:
0.232
Gnomad ASJ
AF:
0.0796
Gnomad EAS
AF:
0.591
Gnomad SAS
AF:
0.210
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.136
Gnomad OTH
AF:
0.126
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.141
AC:
21383
AN:
152140
Hom.:
2456
Cov.:
32
AF XY:
0.150
AC XY:
11180
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0309
AC:
1282
AN:
41548
American (AMR)
AF:
0.233
AC:
3555
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0796
AC:
276
AN:
3466
East Asian (EAS)
AF:
0.592
AC:
3053
AN:
5158
South Asian (SAS)
AF:
0.211
AC:
1018
AN:
4826
European-Finnish (FIN)
AF:
0.246
AC:
2596
AN:
10564
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.136
AC:
9235
AN:
67984
Other (OTH)
AF:
0.123
AC:
260
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
843
1685
2528
3370
4213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0742
Hom.:
96
Bravo
AF:
0.139
Asia WGS
AF:
0.313
AC:
1086
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
12
DANN
Benign
0.68
PhyloP100
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3136460; hg19: chr11-46747065; API